Back

The prevalence and accumulation of main cardiometabolic risk factors among the finnish adult population at different levels of lp(a)

4 April 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: Dyslipidaemia management in 2025: status quo and best practice (1) Cardiovascular Risk Assessment EAPC Premium Access ESC Preventive Cardiology 2025 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Professor Pekka Jousilahti

National Institute for Health and Welfare (THL), Helsinki (Finland)

4 More presentations in this session

Presentation thumbnail
Does the length of evolocumab use contribute to myocardial infarction associated hospital readmissions in patients with ACS?: a single center real world evidence from ELAINE
Doctor O. Wani (Flagstaff, US)
Abstract Slides
Presentation thumbnail
Statin intolerance in a real word setting of Italian cardiology centers: data from the BRING-UP Prevention study
Doctor S. Di Fusco (Rome, IT)
Abstract Slides
Presentation thumbnail
Deficient perceptions and practices concerning elevated lipoprotein(a) among specialists in Singapore
Doctor W. Loh (Singapore, SG)
Abstract Slides
Presentation thumbnail
A collaborative working project in primary care: optimising lipid lowering therapies for secondary prevention in high risk patients
Doctor J. Ward (Westbury, GB)
Abstract Slides

Access the full session

Session thumbnail
Dyslipidaemia management in 2025: status quo and best practice (1)

The Event

Event poster

ESC Preventive Cardiology 2025

4 April 2025 10:00 CET
You may be interested in
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Webinar
Update on dyslipidaemia management: focus on risk estimation and lipoprotein(a)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources